Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crowdstrike Holdings Inc (CRWD) vs Revvity Inc (RVTY) Price & Performance

Crowdstrike Holdings IncTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Crowdstrike Holdings Inc vs Revvity Inc — how do they compare? Crowdstrike Holdings Inc trades at $207.74 (market cap $214.58B), while Revvity Inc trades at $110.83 (market cap $12.41B). The key difference: Crowdstrike Holdings Inc is far larger — about 17.3× Revvity Inc's market cap, and Revvity Inc pays a 0.25% dividend while Crowdstrike Holdings Inc pays none. Which is the better fit depends on your goals.

CRWDRVTY
Market Cap
$214.58B$12.41B
Sector
TechnologyTechnology
52-Week High
$210.73$117.75
52-Week Low
$87.56$82.26
Enterprise Value
$210.85B$14.90B
Dividend Yield
0.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Crowdstrike Holdings Inc

CrowdStrike (CRWD) trades at $187.91, up 0.39% on the day, with a bullish technical signal and strong support near $185. The stock has delivered three consecutive quarterly EPS beats, with Q2 2026 expected at $0.29. Revenue growth remains robust, rising from $1.5B in 2022 to $4.0B in 2025, though net margins are slightly negative. A recent 4-for-1 stock split on July 2, 2026, has increased accessibility amid heightened investor interest in AI-driven cybersecurity.

Outlook is supported by solid cash flow growth and dominant market positioning, but premium valuations (P/E 765, P/S 37) pose risks if growth decelerates. Analyst consensus is strongly bullish with a $184.39 price target, though competitive pressures and execution challenges remain key watchpoints for sustained upside.

Revvity Inc

RVTY trades at $111.11, down 1.05% today, with a bullish technical signal from moving averages. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $1.06 exceeding expectations. Recent developments include AI integration with Anthropic's Claude and FDA clearance for a testosterone assay, signaling innovation in diagnostics and life sciences.

The outlook remains positive with strong analyst support (51.72% buy ratings) and a consensus price target of $111.43. Key risks include margin pressure from China divestment plans and weak academic demand. Revenue stability around $2.9B supports valuation, though high P/E of 53.47 requires sustained growth to justify.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Crowdstrike Holdings Inc

CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.

Read more on CRWD

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY